Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
Status:
Completed
Trial end date:
2018-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Monosialotetrahexosylganglioside sodium
injection can relieve the neurotoxicity caused by oxaliplatin in GI cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital